The trademark application was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on October 12, 2023, and it was registered by office on January 19, 2024 without any oppositions.
It was designated 'Basic Application' for International Application 1784448 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).